Our results indicate that RBPJ+/+ Mφ-Exo may have potential in the regulation of tumor proliferation and hsa_circ_0004658 could be a diagnostic biomarker and potential target for HCC therapy. The gene discussed is RBPJ; the disease is hepatocellular carcinoma.